Looks like a winner: phase2B completed in april17 with promising results from compassionate use trials- should get fast track approval for phase 3- would be interested in your opinion
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.